$284 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 65 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 37.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Sell | BIOGEN INC | $20,710,000 | -7.4% | 65,008 | -9.1% | 7.30% | -16.2% |
| CELG | Buy | CELGENE CORP | $19,833,000 | -24.6% | 190,022 | +5.3% | 6.99% | -31.8% |
| REGN | REGENERON PHARMACEUTICALS | $15,354,000 | -15.9% | 40,830 | 0.0% | 5.41% | -23.8% | |
| NKTR | New | NEKTAR THERAPEUTICS | $12,597,000 | – | 211,000 | +100.0% | 4.44% | – |
| EXEL | Buy | EXELIXIS INC | $12,470,000 | +102.3% | 410,334 | +61.3% | 4.40% | +83.2% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $11,304,000 | -16.2% | 75,422 | -15.0% | 3.98% | -24.1% |
| ADMS | Sell | ADAMAS PHARMACEUTICALS INC | $10,669,000 | +29.3% | 315,000 | -19.2% | 3.76% | +17.1% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $10,047,000 | +10.8% | 333,773 | +38.6% | 3.54% | +0.3% |
| GILD | GILEAD SCIENCES INC | $8,798,000 | -11.5% | 122,784 | 0.0% | 3.10% | -19.9% | |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $8,665,000 | -33.0% | 72,441 | -21.4% | 3.06% | -39.3% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $8,481,000 | +700.8% | 51,496 | +203.0% | 2.99% | +625.7% |
| ENTL | ENTELLUS MED INC | $8,325,000 | +32.1% | 341,468 | 0.0% | 2.94% | +19.6% | |
| STML | Buy | STEMLINE THERAPEUTICS INC | $7,690,000 | +278.6% | 492,930 | +169.5% | 2.71% | +242.7% |
| INCY | Sell | INCYTE CORP | $6,912,000 | -33.4% | 72,975 | -18.0% | 2.44% | -39.7% |
| TSRO | Buy | TESARO INC | $6,406,000 | +41.8% | 77,300 | +120.9% | 2.26% | +28.4% |
| AMGN | AMGEN INC | $6,279,000 | -6.7% | 36,104 | 0.0% | 2.21% | -15.5% | |
| ARRY | Buy | ARRAY BIOPHARMA INC | $6,112,000 | +100.8% | 477,500 | +92.9% | 2.16% | +81.9% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,097,000 | -4.2% | 68,384 | 0.0% | 2.15% | -13.2% | |
| HALO | HALOZYME THERAPEUTICS INC | $5,723,000 | +16.6% | 282,633 | 0.0% | 2.02% | +5.7% | |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $5,168,000 | +12.0% | 76,000 | +35.7% | 1.82% | +1.4% |
| SHPG | New | SHIRE PLCsponsored adr | $4,839,000 | – | 31,200 | +100.0% | 1.71% | – |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $4,675,000 | -3.6% | 36,800 | -10.9% | 1.65% | -12.7% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $4,538,000 | -10.5% | 253,500 | +25.5% | 1.60% | -18.9% |
| LGND | LIGAND PHARMACEUTICALS INC | $3,971,000 | +0.6% | 29,000 | 0.0% | 1.40% | -8.9% | |
| BLUE | BLUEBIRD BIO INC | $3,560,000 | +29.6% | 20,000 | 0.0% | 1.26% | +17.4% | |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS | $3,358,000 | +20.0% | 1,505,804 | +54.9% | 1.18% | +8.6% |
| KALV | KALVISTA PHARMACEUTICALS INC | $3,137,000 | +46.1% | 322,436 | 0.0% | 1.11% | +32.3% | |
| SGEN | SEATTLE GENETICS INC | $3,077,000 | -1.7% | 57,500 | 0.0% | 1.08% | -10.9% | |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $3,034,000 | -25.9% | 185,000 | -32.2% | 1.07% | -32.9% |
| DERM | DERMIRA INC | $3,004,000 | +3.0% | 108,000 | 0.0% | 1.06% | -6.7% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,871,000 | -29.0% | 37,000 | -43.9% | 1.01% | -35.7% |
| IONS | IONIS PHARMACEUTICALS INC | $2,589,000 | -0.8% | 51,500 | 0.0% | 0.91% | -10.1% | |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $2,531,000 | -28.4% | 115,500 | +33.5% | 0.89% | -35.2% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $2,476,000 | +641.3% | 247,587 | +414.3% | 0.87% | +571.5% |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $2,301,000 | – | 382,838 | +100.0% | 0.81% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $2,293,000 | – | 25,000 | +100.0% | 0.81% | – |
| JUNO | Sell | JUNO THERAPEUTICS INC | $2,284,000 | -19.1% | 50,000 | -20.6% | 0.80% | -26.8% |
| AKAOQ | Buy | ACHAOGEN INC | $2,197,000 | +84.8% | 204,538 | +174.4% | 0.78% | +67.4% |
| AVXS | AVEXIS INC | $1,881,000 | +14.4% | 17,000 | 0.0% | 0.66% | +3.6% | |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS INC | $1,746,000 | +265.3% | 77,000 | +208.0% | 0.62% | +231.2% |
| ANAB | New | ANAPTYSBIO INC | $1,711,000 | – | 17,000 | +100.0% | 0.60% | – |
| TRXC | TRANSENTERIX INC | $1,707,000 | +34.3% | 889,082 | 0.0% | 0.60% | +21.6% | |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $1,502,000 | -72.6% | 27,000 | -77.7% | 0.53% | -75.2% |
| FGEN | FIBROGEN INC | $1,488,000 | -11.8% | 31,400 | 0.0% | 0.52% | -20.1% | |
| New | MERUS NV | $1,413,000 | – | 75,060 | +100.0% | 0.50% | – | |
| CBAY | New | CYMABAY THERAPEUTICS INC | $1,334,000 | – | 145,000 | +100.0% | 0.47% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $1,267,000 | – | 9,600 | +100.0% | 0.45% | – |
| OPTN | New | OPTINOSE INC | $1,228,000 | – | 65,000 | +100.0% | 0.43% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $1,186,000 | – | 12,000 | +100.0% | 0.42% | – |
| PTLA | PORTOLA PHARMACEUTICALS INC | $1,168,000 | -9.9% | 24,000 | 0.0% | 0.41% | -18.4% | |
| RSLS | New | RESHAPE LIFESCIENCES INC | $1,151,000 | – | 788,194 | +100.0% | 0.41% | – |
| AGIO | AGIOS PHARMACEUTICALS INC | $1,143,000 | -14.3% | 20,000 | 0.0% | 0.40% | -22.4% | |
| HZNP | HORIZON PHARMA PLC | $1,007,000 | +15.0% | 69,000 | 0.0% | 0.36% | +4.1% | |
| SBPH | New | SPRING BR PHARMACEUTICALS INC | $956,000 | – | 73,000 | +100.0% | 0.34% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $928,000 | – | 9,500 | +100.0% | 0.33% | – |
| AERI | AERIE PHARMACEUTICALS INC | $883,000 | +23.0% | 14,779 | 0.0% | 0.31% | +11.5% | |
| FOLD | AMICUS THERAPEUTICS INC | $843,000 | -4.5% | 58,600 | 0.0% | 0.30% | -13.7% | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | $834,000 | -0.5% | 20,953 | 0.0% | 0.29% | -9.8% | |
| GTHX | G1 THERAPEUTICS INC | $773,000 | -20.4% | 39,000 | 0.0% | 0.27% | -27.8% | |
| OMER | Sell | OMEROS CORP | $660,000 | -50.0% | 34,000 | -44.3% | 0.23% | -54.6% |
| ONCE | SPARK THERAPEUTICS INC | $617,000 | -42.3% | 12,000 | 0.0% | 0.22% | -47.6% | |
| RDUS | RADIUS HEALTH INC | $597,000 | -17.7% | 18,799 | 0.0% | 0.21% | -25.5% | |
| PRTA | New | PROTHENA CORP PLC | $562,000 | – | 15,000 | +100.0% | 0.20% | – |
| XNCR | XENCOR INC | $395,000 | -4.4% | 18,000 | 0.0% | 0.14% | -13.7% | |
| VKTX | New | VIKING THERAPEUTICS INC | $284,000 | – | 70,000 | +100.0% | 0.10% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -5,104 | -100.0% | -0.07% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -59,000 | -100.0% | -0.36% | – |
| VCYT | Exit | VERACYTE INC | $0 | – | -170,000 | -100.0% | -0.58% | – |
| CORT | Exit | CORCEPT THERAPEUTICS INC | $0 | – | -83,000 | -100.0% | -0.62% | – |
| CALA | Exit | CALITHERA BIOSCIENCES | $0 | – | -188,000 | -100.0% | -1.15% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -153,633 | -100.0% | -2.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-03-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.